SpringerLink
Log in

Tumor Specific Peptides Selected for Targeted Delivery of Therapeutic Agents to Glioma Human Cells

  • Published:
Russian Journal of Bioorganic Chemistry Aims and scope Submit manuscript

Abstract—

Brain tumors are among the most intractable types of malignant neoplasms. Despite advances in the treatment of cancer, in particular, the development of new approaches in surgery, radiotherapy and chemotherapy, the incidence remains high with a low 5-year survival rate. Targeted therapy (TT) may be a solution to the problem of low efficacy of the applied cancer treatment methods. TT is based on the use of drugs that specifically affect specific types of tumors, which allows one to increase the effectiveness of treatment and minimize toxic effects on healthy tissues of the body. The combination of the unique properties of cancer cells allows one to find specific ligands that interact directly with the tumor, and to conduct TT for malignant tumors. Phage display technology is one of the promising approaches to the search for tissue- and/or organ-specific molecules [1]. Combinatorial phage peptide libraries make it possible to obtain highly specific peptides, including for various types of tumors. Currently, such tumor-targeting peptides are considered as means of targeted delivery of therapeutic genes, cytokines, imaging agents, pro-apoptotic peptides, and cytotoxic drugs. The purpose of this work was to obtain from the phage peptide library of bacteriophages exposing peptides, which ensure the accumulation of phage particles in human glioblastoma cells U-87 MG, and to assess the specificity of the selected peptides for cells of the primary cultures of human gliomas. During the research, the following tasks were solved: (1) Tumor-targeting peptides were selected using human glioblastoma cells U-87 MG in vitro and on a U-87 MG tumor in a xenograft model in vivo; amino acid sequences of selected peptides (SWTFGVQFALQH (26), HPSSGSA (92), PVSNKMS (83)) were determined; (2) primary cultures of human gliomas AS2, MG1, MG2, MG3, MG4 cells were obtained and characterized; (3) specificity of the binding of bacteriophages exposing selected tumor-targeting peptides to cells of primary cultures of human gliomas was evaluated using immunocytochemical analysis. The specific binding of selected tumor-targeting peptides with cells of the primary cultures AS2, MG1 was shown.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price includes VAT (Germany)

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1.
Fig. 2.
Fig. 3.
Fig. 4.
Fig. 5.
Fig. 6.
Fig. 7.

Similar content being viewed by others

REFERENCES

  1. Kehoe, J.W. and Kay, B.K., Chem. Rev., 2005, vol. 105, no. 11, pp. 4056–72.

    Article  CAS  Google Scholar 

  2. Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R.L., Torre, L.A., and Jemal, A., Ca—Cancer J. Clin., 2018, vol. 68, no. 6, pp. 394–424.

    Article  Google Scholar 

  3. Komori, T., Neurol. Med. Chir. (Tokyo), 2017, vol. 57, pp. 301–311.

    Article  Google Scholar 

  4. Lara-Velazquez, M., Al-Kharboosh, R., Jeanneret, S., Vazquez-Ramos, C., Mahato, D., Tavanaiepour, D., Rahmathulla, G., and Quinones-Hinojosa, A., Brain Sci., 2017, vol. 7, no. 12, p. E166.

  5. Wu, D., Gao, Y., Qi, Y., Chen, L., Ma, Y., and Li, Y., Cancer Lett., 2014, vol. 351, no. 1, pp. 13–22.

    Article  CAS  Google Scholar 

  6. Saw, P.E. and Song, E.-W., Protein Cell, 2019, pp. 1–21.

  7. Garg, P., J. Cancer Res. Ther. 2019, vol. 15, no. 8, p. 1.

    Article  Google Scholar 

  8. Borgoyakova, M.B. and Karpenko, L.I., Biol. Med., 2015, vol. s2. https://doi.org/10.4172/0974-8369.S2-002.

  9. Allen, M., Bjerke, M., Edlund, H., Nelander, S., and Westermark, B., Sci. Transl. Med., 2016, vol. 8, no. 354, p. 354.

    Article  Google Scholar 

  10. Lau, J.L. and Dunn, M.K., Bioorg. Med. Chem., 2018, vol. 26, no. 10, pp. 2700–2707.

    Article  CAS  Google Scholar 

  11. Marsh, W., Exploiting Phage Display for Development of Novel Cellular Targeting Strategies, New York: Humana Press, 2018.

    Book  Google Scholar 

  12. Nemudraya, A.A., Makartsova, A.A., Fomin, A.S., Nushtaeva, A.A., Koval, O.A., Richter, V.A., and Kuligina, E.V., PLoS One, 2016, vol. 11, no. 8. e0160980.

    Article  Google Scholar 

  13. Soendergaard, M., Newton-Northup, J.R., and Deutscher, S.L., Am. J. Nuclear Med. Mol. Imaging, 2014, vol. 4, no. 6, pp. 561–570.

    CAS  Google Scholar 

  14. Wickramasinghe, S.N., Cell Biochem. Funct., 1996, vol. 14, no. 1, pp. 75–76.

    Google Scholar 

  15. Fischer, A.H., Jacobson, K.A., Rose, J., and Zeller, R., Cold Spring Harbor Protoc., 2008, vol. 2008, no. 6, p. 4986.

    Google Scholar 

Download references

ACKNOWLEDGMENTS

The authors thank R.I. Baiborodin, the Head of the Core Facilities Center “Microscopic Analysis of Biological Objects,” SB RAS, for assistance in conducting confocal microscopy.

Funding

This study was supported by the Russian Science Fund (grant no. 19-44-02006). We also acknowledge Russian State funded budget project of ICBFM SB RAS АААА-А17-117020210023-1 for supporting this work.

Author information

Authors and Affiliations

  1. Institute of Chemical Biology and Fundamental Medicine, SB RAS, 630090, Novosibirsk, Russia

    A. A. Voitova, M. D. Dmitrieva, M. A. Dymova, N. S. Vasileva, A. A. Nushtaeva, V. A. Richter & E. V. Kuligina

Authors
  1. A. A. Voitova
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. D. Dmitrieva
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M. A. Dymova
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. N. S. Vasileva
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. A. A. Nushtaeva
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. V. A. Richter
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. E. V. Kuligina
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to M. A. Dymova.

Ethics declarations

All applicable international, national, and/or institutional ethical standards were followed.

Conflict of Interests

The authors declare that they have no conflict of interest.

Additional information

Translated by M. Novikova

Abbreviations: ТТ, targeted therapy; WHO, World health organization; PFU, plaque forming unit; PBS, phosphate buffer saline; BSA, bovine serum albumin; PBST, phosphate buffer saline with Tween 20; IPTG, isopropyl β-D-1-thiogalactopyranoside; PEG, polyethylene glycol; ssDNA, single-strand deoxyribonucleic acid; DMEM/RPMI, culture medium (Dulbecco’s Modified Eagle Media/Roswell Park Memorial Institute); FBS, fetal bovine serum.

Corresponding author: phone: +7 (913) 476-40-12; e-mail: maya.a.rot@gmail.com.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Voitova, A.A., Dmitrieva, M.D., Dymova, M.A. et al. Tumor Specific Peptides Selected for Targeted Delivery of Therapeutic Agents to Glioma Human Cells. Russ J Bioorg Chem 45, 783–792 (2019). https://doi.org/10.1134/S1068162019060384

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1134/S1068162019060384

Keywords:

Search

Navigation